Q1 2015 13F Holders as of 3/31/2015
-
Type / Class
-
Equity / Common Stock, $0.01 par value
-
Shares outstanding
-
101M
-
Number of holders
-
73
-
Total 13F shares, excl. options
-
14.3M
-
Shares change
-
+349K
-
Total reported value, excl. options
-
$448M
-
Value change
-
+$11.9M
-
Number of buys
-
43
-
Number of sells
-
-24
-
Price
-
$31.38
Significant Holders of FIBROGEN INC - Common Stock, $0.01 par value (FGEN) as of Q1 2015
81 filings reported holding FGEN - FIBROGEN INC - Common Stock, $0.01 par value as of Q1 2015.
FIBROGEN INC - Common Stock, $0.01 par value (FGEN) has 73 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 14.3M shares
of 101M outstanding shares and own 14.15% of the company stock.
Largest 10 shareholders include ADAGE CAPITAL PARTNERS GP LLC (2.49M shares), WADDELL & REED FINANCIAL INC (1.34M shares), OZ Management LP (1.32M shares), BROOKSIDE CAPITAL MANAGEMENT LLC (1.2M shares), PRICE T ROWE ASSOCIATES INC /MD/ (977K shares), Visium Asset Management, LP (823K shares), FMR LLC (799K shares), JANUS CAPITAL MANAGEMENT LLC (574K shares), GOLDMAN SACHS GROUP INC (510K shares), and JPMORGAN CHASE & CO (481K shares).
This table shows the top 73 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.